Recommendation ID
NG198/1
Question

What is the efficacy of reduced dose oral isotretinoin in the management of acne vulgaris?

Any explanatory notes
(if applicable)

For a short explanation of why the committee made the recommendation for research, see the rationale section on oral isotretinoin treatment .

Full details of the evidence and the committee's discussion are in evidence review F1: management options for moderate to severe acne – network meta-analyses.


Source guidance details

Comes from guidance
Acne vulgaris: management
Number
NG198
Date issued
June 2021

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 01/01/2024